nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—rheumatoid arthritis—Gabapentin—epilepsy syndrome	0.185	1	CpDpCtD
Lidocaine—SCN9A—epilepsy syndrome	0.0754	0.268	CbGaD
Lidocaine—SCN3A—epilepsy syndrome	0.0722	0.256	CbGaD
Lidocaine—SCN4A—epilepsy syndrome	0.0693	0.246	CbGaD
Lidocaine—SCN2A—epilepsy syndrome	0.0447	0.158	CbGaD
Lidocaine—CYP2D6—epilepsy syndrome	0.0118	0.0419	CbGaD
Lidocaine—SCN9A—Lacosamide—epilepsy syndrome	0.0106	0.0282	CbGbCtD
Lidocaine—SCN9A—Lamotrigine—epilepsy syndrome	0.0106	0.0282	CbGbCtD
Lidocaine—SCN3A—Lacosamide—epilepsy syndrome	0.00965	0.0258	CbGbCtD
Lidocaine—SCN3A—Lamotrigine—epilepsy syndrome	0.00965	0.0258	CbGbCtD
Lidocaine—SCN9A—Rufinamide—epilepsy syndrome	0.00932	0.0249	CbGbCtD
Lidocaine—SCN9A—Carbamazepine—epilepsy syndrome	0.00908	0.0243	CbGbCtD
Lidocaine—SCN2A—Lamotrigine—epilepsy syndrome	0.00891	0.0238	CbGbCtD
Lidocaine—SCN4A—Lamotrigine—epilepsy syndrome	0.00891	0.0238	CbGbCtD
Lidocaine—SCN3A—Rufinamide—epilepsy syndrome	0.00853	0.0228	CbGbCtD
Lidocaine—ABCB1—epilepsy syndrome	0.00842	0.0299	CbGaD
Lidocaine—SCN10A—Lacosamide—epilepsy syndrome	0.00828	0.0221	CbGbCtD
Lidocaine—SCN10A—Lamotrigine—epilepsy syndrome	0.00828	0.0221	CbGbCtD
Lidocaine—SCN9A—Phenytoin—epilepsy syndrome	0.00815	0.0218	CbGbCtD
Lidocaine—SCN4A—Rufinamide—epilepsy syndrome	0.00787	0.021	CbGbCtD
Lidocaine—SCN2A—Rufinamide—epilepsy syndrome	0.00787	0.021	CbGbCtD
Lidocaine—SCN5A—Oxcarbazepine—epilepsy syndrome	0.00776	0.0207	CbGbCtD
Lidocaine—SCN4A—Carbamazepine—epilepsy syndrome	0.00767	0.0205	CbGbCtD
Lidocaine—SCN3A—Phenytoin—epilepsy syndrome	0.00745	0.0199	CbGbCtD
Lidocaine—CYP2C18—Clobazam—epilepsy syndrome	0.00735	0.0196	CbGbCtD
Lidocaine—SCN10A—Rufinamide—epilepsy syndrome	0.00732	0.0195	CbGbCtD
Lidocaine—SCN4A—Phenytoin—epilepsy syndrome	0.00688	0.0184	CbGbCtD
Lidocaine—SCN2A—Phenytoin—epilepsy syndrome	0.00688	0.0184	CbGbCtD
Lidocaine—SCN5A—Fosphenytoin—epilepsy syndrome	0.00679	0.0181	CbGbCtD
Lidocaine—SCN9A—Zonisamide—epilepsy syndrome	0.00672	0.0179	CbGbCtD
Lidocaine—SCN2A—Propofol—epilepsy syndrome	0.00642	0.0171	CbGbCtD
Lidocaine—SCN4A—Propofol—epilepsy syndrome	0.00642	0.0171	CbGbCtD
Lidocaine—SCN3A—Zonisamide—epilepsy syndrome	0.00615	0.0164	CbGbCtD
Lidocaine—SCN2A—Zonisamide—epilepsy syndrome	0.00567	0.0151	CbGbCtD
Lidocaine—SCN4A—Zonisamide—epilepsy syndrome	0.00567	0.0151	CbGbCtD
Lidocaine—SCN5A—Lamotrigine—epilepsy syndrome	0.00566	0.0151	CbGbCtD
Lidocaine—CYP2C18—Phenytoin—epilepsy syndrome	0.00547	0.0146	CbGbCtD
Lidocaine—CYP2C18—Propofol—epilepsy syndrome	0.0051	0.0136	CbGbCtD
Lidocaine—SCN5A—Rufinamide—epilepsy syndrome	0.005	0.0134	CbGbCtD
Lidocaine—SCN5A—Carbamazepine—epilepsy syndrome	0.00488	0.013	CbGbCtD
Lidocaine—CYP2C18—Phenobarbital—epilepsy syndrome	0.00487	0.013	CbGbCtD
Lidocaine—CYP2C18—Diazepam—epilepsy syndrome	0.00462	0.0123	CbGbCtD
Lidocaine—SCN5A—Phenytoin—epilepsy syndrome	0.00437	0.0117	CbGbCtD
Lidocaine—CYP2C18—Valproic Acid—epilepsy syndrome	0.00364	0.00972	CbGbCtD
Lidocaine—SCN5A—Zonisamide—epilepsy syndrome	0.00361	0.00963	CbGbCtD
Lidocaine—CYP2A6—Amobarbital—epilepsy syndrome	0.00332	0.00887	CbGbCtD
Lidocaine—SCN3A—spinal nerve—epilepsy syndrome	0.00327	0.222	CbGeAlD
Lidocaine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00268	0.00716	CbGbCtD
Lidocaine—SCN5A—Topiramate—epilepsy syndrome	0.00263	0.00702	CbGbCtD
Lidocaine—CYP2A6—Propofol—epilepsy syndrome	0.00248	0.00661	CbGbCtD
Lidocaine—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00242	0.00646	CbGbCtD
Lidocaine—CYP2A6—Phenobarbital—epilepsy syndrome	0.00237	0.00632	CbGbCtD
Lidocaine—CYP2B6—Clobazam—epilepsy syndrome	0.00233	0.00621	CbGbCtD
Lidocaine—SLC22A5—Valproic Acid—epilepsy syndrome	0.00233	0.00621	CbGbCtD
Lidocaine—CYP2C8—Trimethadione—epilepsy syndrome	0.00216	0.00577	CbGbCtD
Lidocaine—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00203	0.00543	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00202	0.00541	CbGbCtD
Lidocaine—CYP3A7—Carbamazepine—epilepsy syndrome	0.00202	0.00541	CbGbCtD
Lidocaine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00193	0.00515	CbGbCtD
Lidocaine—CYP3A7—Phenytoin—epilepsy syndrome	0.00182	0.00485	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00182	0.00485	CbGbCtD
Lidocaine—CYP2B6—Primidone—epilepsy syndrome	0.0018	0.00481	CbGbCtD
Lidocaine—CYP2A6—Valproic Acid—epilepsy syndrome	0.00177	0.00472	CbGbCtD
Lidocaine—CYP2B6—Phenytoin—epilepsy syndrome	0.00173	0.00462	CbGbCtD
Lidocaine—ABCB1—Levetiracetam—epilepsy syndrome	0.00172	0.00459	CbGbCtD
Lidocaine—CYP3A7—Phenobarbital—epilepsy syndrome	0.00162	0.00432	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00162	0.00432	CbGbCtD
Lidocaine—CYP2B6—Propofol—epilepsy syndrome	0.00161	0.00431	CbGbCtD
Lidocaine—CYP3A7—Midazolam—epilepsy syndrome	0.0016	0.00426	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.0016	0.00426	CbGbCtD
Lidocaine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00154	0.00412	CbGbCtD
Lidocaine—CYP3A7—Diazepam—epilepsy syndrome	0.00153	0.0041	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00153	0.0041	CbGbCtD
Lidocaine—CYP2B6—Midazolam—epilepsy syndrome	0.00152	0.00406	CbGbCtD
Lidocaine—CYP3A5—Carbamazepine—epilepsy syndrome	0.00152	0.00405	CbGbCtD
Lidocaine—CYP2C9—Trimethadione—epilepsy syndrome	0.00151	0.00403	CbGbCtD
Lidocaine—CYP2B6—Diazepam—epilepsy syndrome	0.00146	0.0039	CbGbCtD
Lidocaine—CYP2C8—Carbamazepine—epilepsy syndrome	0.00146	0.0039	CbGbCtD
Lidocaine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00142	0.00378	CbGbCtD
Lidocaine—CYP2C8—Primidone—epilepsy syndrome	0.00136	0.00364	CbGbCtD
Lidocaine—CYP3A5—Phenytoin—epilepsy syndrome	0.00136	0.00364	CbGbCtD
Lidocaine—CYP2C8—Phenytoin—epilepsy syndrome	0.00131	0.0035	CbGbCtD
Lidocaine—CYP2C8—Propofol—epilepsy syndrome	0.00122	0.00326	CbGbCtD
Lidocaine—CYP3A5—Phenobarbital—epilepsy syndrome	0.00121	0.00324	CbGbCtD
Lidocaine—CYP3A5—Midazolam—epilepsy syndrome	0.0012	0.0032	CbGbCtD
Lidocaine—ABCB1—Clobazam—epilepsy syndrome	0.00119	0.00318	CbGbCtD
Lidocaine—CYP2C8—Phenobarbital—epilepsy syndrome	0.00117	0.00312	CbGbCtD
Lidocaine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00115	0.00308	CbGbCtD
Lidocaine—CYP3A5—Diazepam—epilepsy syndrome	0.00115	0.00307	CbGbCtD
Lidocaine—ABCB1—Lamotrigine—epilepsy syndrome	0.00115	0.00307	CbGbCtD
Lidocaine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00113	0.00302	CbGbCtD
Lidocaine—CYP2C8—Diazepam—epilepsy syndrome	0.00111	0.00295	CbGbCtD
Lidocaine—CYP1A2—Primidone—epilepsy syndrome	0.00106	0.00282	CbGbCtD
Lidocaine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00102	0.00272	CbGbCtD
Lidocaine—ABCB1—Carbamazepine—epilepsy syndrome	0.000988	0.00264	CbGbCtD
Lidocaine—CYP2C9—Primidone—epilepsy syndrome	0.000951	0.00254	CbGbCtD
Lidocaine—CYP1A2—Propofol—epilepsy syndrome	0.000945	0.00252	CbGbCtD
Lidocaine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.000943	0.00252	CbGbCtD
Lidocaine—CYP2C9—Phenytoin—epilepsy syndrome	0.000913	0.00244	CbGbCtD
Lidocaine—CYP3A5—Valproic Acid—epilepsy syndrome	0.000907	0.00242	CbGbCtD
Lidocaine—CYP1A2—Phenobarbital—epilepsy syndrome	0.000904	0.00241	CbGbCtD
Lidocaine—ABCB1—Phenytoin—epilepsy syndrome	0.000886	0.00237	CbGbCtD
Lidocaine—CYP3A4—Felbamate—epilepsy syndrome	0.000877	0.00234	CbGbCtD
Lidocaine—CYP3A4—Trimethadione—epilepsy syndrome	0.000877	0.00234	CbGbCtD
Lidocaine—CYP2C8—Valproic Acid—epilepsy syndrome	0.000872	0.00233	CbGbCtD
Lidocaine—CYP1A2—Diazepam—epilepsy syndrome	0.000857	0.00229	CbGbCtD
Lidocaine—CYP2C9—Propofol—epilepsy syndrome	0.000852	0.00227	CbGbCtD
Lidocaine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.000824	0.0022	CbGbCtD
Lidocaine—CYP2C9—Phenobarbital—epilepsy syndrome	0.000814	0.00217	CbGbCtD
Lidocaine—ABCB1—Phenobarbital—epilepsy syndrome	0.00079	0.00211	CbGbCtD
Lidocaine—ABCB1—Midazolam—epilepsy syndrome	0.000779	0.00208	CbGbCtD
Lidocaine—CYP2D6—Propofol—epilepsy syndrome	0.000779	0.00208	CbGbCtD
Lidocaine—CYP2C9—Diazepam—epilepsy syndrome	0.000772	0.00206	CbGbCtD
Lidocaine—ABCB1—Diazepam—epilepsy syndrome	0.000749	0.002	CbGbCtD
Lidocaine—CYP3A4—Clonazepam—epilepsy syndrome	0.000745	0.00199	CbGbCtD
Lidocaine—CYP3A4—Clobazam—epilepsy syndrome	0.000715	0.00191	CbGbCtD
Lidocaine—SCN10A—ganglion—epilepsy syndrome	0.000682	0.0462	CbGeAlD
Lidocaine—CYP1A2—Valproic Acid—epilepsy syndrome	0.000675	0.0018	CbGbCtD
Lidocaine—CYP2C9—Valproic Acid—epilepsy syndrome	0.000608	0.00162	CbGbCtD
Lidocaine—CYP3A4—Rufinamide—epilepsy syndrome	0.000608	0.00162	CbGbCtD
Lidocaine—CYP3A4—Carbamazepine—epilepsy syndrome	0.000592	0.00158	CbGbCtD
Lidocaine—CYP3A4—Primidone—epilepsy syndrome	0.000553	0.00148	CbGbCtD
Lidocaine—SCN2A—hindbrain—epilepsy syndrome	0.000536	0.0364	CbGeAlD
Lidocaine—CYP3A4—Phenytoin—epilepsy syndrome	0.000531	0.00142	CbGbCtD
Lidocaine—CYP3A4—Propofol—epilepsy syndrome	0.000495	0.00132	CbGbCtD
Lidocaine—CYP3A4—Phenobarbital—epilepsy syndrome	0.000473	0.00126	CbGbCtD
Lidocaine—CYP3A4—Acetazolamide—epilepsy syndrome	0.000473	0.00126	CbGbCtD
Lidocaine—CYP3A4—Midazolam—epilepsy syndrome	0.000467	0.00125	CbGbCtD
Lidocaine—CYP3A4—Diazepam—epilepsy syndrome	0.000449	0.0012	CbGbCtD
Lidocaine—CYP3A4—Zonisamide—epilepsy syndrome	0.000438	0.00117	CbGbCtD
Lidocaine—EGFR—telencephalon—epilepsy syndrome	0.00042	0.0285	CbGeAlD
Lidocaine—Etidocaine—SCN4A—epilepsy syndrome	0.000356	0.11	CrCbGaD
Lidocaine—CYP3A4—Valproic Acid—epilepsy syndrome	0.000354	0.000945	CbGbCtD
Lidocaine—CYP3A4—Topiramate—epilepsy syndrome	0.000319	0.000852	CbGbCtD
Lidocaine—SCN2A—brainstem—epilepsy syndrome	0.000307	0.0208	CbGeAlD
Lidocaine—SCN2A—forebrain—epilepsy syndrome	0.000297	0.0201	CbGeAlD
Lidocaine—SCN10A—forebrain—epilepsy syndrome	0.000286	0.0194	CbGeAlD
Lidocaine—SCN2A—telencephalon—epilepsy syndrome	0.000273	0.0185	CbGeAlD
Lidocaine—SCN10A—telencephalon—epilepsy syndrome	0.000263	0.0178	CbGeAlD
Lidocaine—SCN3A—forebrain—epilepsy syndrome	0.000261	0.0177	CbGeAlD
Lidocaine—SCN9A—midbrain—epilepsy syndrome	0.000248	0.0168	CbGeAlD
Lidocaine—SCN9A—spinal cord—epilepsy syndrome	0.000242	0.0164	CbGeAlD
Lidocaine—SCN3A—telencephalon—epilepsy syndrome	0.00024	0.0163	CbGeAlD
Lidocaine—EGFR—cerebellum—epilepsy syndrome	0.000233	0.0158	CbGeAlD
Lidocaine—Etidocaine—SCN2A—epilepsy syndrome	0.00023	0.0708	CrCbGaD
Lidocaine—SCN2A—medulla oblongata—epilepsy syndrome	0.000214	0.0145	CbGeAlD
Lidocaine—SCN2A—midbrain—epilepsy syndrome	0.000196	0.0133	CbGeAlD
Lidocaine—SCN4A—head—epilepsy syndrome	0.000192	0.013	CbGeAlD
Lidocaine—SCN2A—spinal cord—epilepsy syndrome	0.000191	0.013	CbGeAlD
Lidocaine—EGFR—brain—epilepsy syndrome	0.000189	0.0128	CbGeAlD
Lidocaine—SCN3A—medulla oblongata—epilepsy syndrome	0.000188	0.0128	CbGeAlD
Lidocaine—SCN10A—spinal cord—epilepsy syndrome	0.000184	0.0125	CbGeAlD
Lidocaine—SCN4A—nervous system—epilepsy syndrome	0.000182	0.0123	CbGeAlD
Lidocaine—CYP2D6—hindbrain—epilepsy syndrome	0.000176	0.012	CbGeAlD
Lidocaine—SCN4A—central nervous system—epilepsy syndrome	0.000175	0.0119	CbGeAlD
Lidocaine—SCN3A—midbrain—epilepsy syndrome	0.000172	0.0117	CbGeAlD
Lidocaine—Mepivacaine—SCN8A—epilepsy syndrome	0.00017	0.0525	CrCbGaD
Lidocaine—SCN2A—head—epilepsy syndrome	0.00017	0.0115	CbGeAlD
Lidocaine—SCN3A—spinal cord—epilepsy syndrome	0.000168	0.0114	CbGeAlD
Lidocaine—SCN10A—head—epilepsy syndrome	0.000164	0.0111	CbGeAlD
Lidocaine—SCN2A—nervous system—epilepsy syndrome	0.000161	0.0109	CbGeAlD
Lidocaine—SCN9A—brain—epilepsy syndrome	0.000156	0.0106	CbGeAlD
Lidocaine—SCN10A—nervous system—epilepsy syndrome	0.000155	0.0105	CbGeAlD
Lidocaine—Levobupivacaine—SCN4A—epilepsy syndrome	0.000155	0.0478	CrCbGaD
Lidocaine—SCN2A—central nervous system—epilepsy syndrome	0.000155	0.0105	CbGeAlD
Lidocaine—SCN2A—cerebellum—epilepsy syndrome	0.000152	0.0103	CbGeAlD
Lidocaine—SCN10A—central nervous system—epilepsy syndrome	0.000149	0.0101	CbGeAlD
Lidocaine—SCN3A—head—epilepsy syndrome	0.000149	0.0101	CbGeAlD
Lidocaine—SCN5A—head—epilepsy syndrome	0.000149	0.0101	CbGeAlD
Lidocaine—SCN3A—nervous system—epilepsy syndrome	0.000142	0.0096	CbGeAlD
Lidocaine—SCN5A—nervous system—epilepsy syndrome	0.000141	0.00957	CbGeAlD
Lidocaine—SCN4A—brain—epilepsy syndrome	0.000139	0.00943	CbGeAlD
Lidocaine—Mepivacaine—SCN9A—epilepsy syndrome	0.000138	0.0424	CrCbGaD
Lidocaine—SCN3A—central nervous system—epilepsy syndrome	0.000136	0.00924	CbGeAlD
Lidocaine—SCN5A—central nervous system—epilepsy syndrome	0.000136	0.00921	CbGeAlD
Lidocaine—Ropivacaine—SCN8A—epilepsy syndrome	0.000135	0.0415	CrCbGaD
Lidocaine—SCN3A—cerebellum—epilepsy syndrome	0.000133	0.00903	CbGeAlD
Lidocaine—CYP2A6—cerebellum—epilepsy syndrome	0.000133	0.00903	CbGeAlD
Lidocaine—Mepivacaine—SCN3A—epilepsy syndrome	0.000132	0.0406	CrCbGaD
Lidocaine—Mepivacaine—SCN4A—epilepsy syndrome	0.000126	0.039	CrCbGaD
Lidocaine—Tocainide—SCN8A—epilepsy syndrome	0.000126	0.039	CrCbGaD
Lidocaine—Bupivacaine—SCN4A—epilepsy syndrome	0.000124	0.0382	CrCbGaD
Lidocaine—SCN2A—brain—epilepsy syndrome	0.000123	0.00835	CbGeAlD
Lidocaine—SCN10A—brain—epilepsy syndrome	0.000119	0.00805	CbGeAlD
Lidocaine—SLC22A5—medulla oblongata—epilepsy syndrome	0.000109	0.0074	CbGeAlD
Lidocaine—Ropivacaine—SCN9A—epilepsy syndrome	0.000109	0.0335	CrCbGaD
Lidocaine—SCN3A—brain—epilepsy syndrome	0.000108	0.00734	CbGeAlD
Lidocaine—CYP2A6—brain—epilepsy syndrome	0.000108	0.00733	CbGeAlD
Lidocaine—SCN5A—brain—epilepsy syndrome	0.000108	0.00732	CbGeAlD
Lidocaine—Ropivacaine—SCN3A—epilepsy syndrome	0.000104	0.0321	CrCbGaD
Lidocaine—Tocainide—SCN9A—epilepsy syndrome	0.000102	0.0315	CrCbGaD
Lidocaine—CYP2D6—brainstem—epilepsy syndrome	0.000101	0.00685	CbGeAlD
Lidocaine—Ropivacaine—SCN4A—epilepsy syndrome	0.0001	0.0308	CrCbGaD
Lidocaine—SLC22A5—midbrain—epilepsy syndrome	9.98e-05	0.00677	CbGeAlD
Lidocaine—Tocainide—SCN3A—epilepsy syndrome	9.78e-05	0.0302	CrCbGaD
Lidocaine—CYP2D6—forebrain—epilepsy syndrome	9.75e-05	0.00661	CbGeAlD
Lidocaine—SLC22A5—spinal cord—epilepsy syndrome	9.73e-05	0.0066	CbGeAlD
Lidocaine—Tocainide—SCN4A—epilepsy syndrome	9.4e-05	0.029	CrCbGaD
Lidocaine—Mepivacaine—SCN1A—epilepsy syndrome	9.24e-05	0.0285	CrCbGaD
Lidocaine—CYP2D6—telencephalon—epilepsy syndrome	8.96e-05	0.00608	CbGeAlD
Lidocaine—Mepivacaine—SCN2A—epilepsy syndrome	8.15e-05	0.0251	CrCbGaD
Lidocaine—Procainamide—SCN8A—epilepsy syndrome	7.81e-05	0.0241	CrCbGaD
Lidocaine—SLC22A5—cerebellum—epilepsy syndrome	7.72e-05	0.00523	CbGeAlD
Lidocaine—CYP2B6—head—epilepsy syndrome	7.51e-05	0.00509	CbGeAlD
Lidocaine—Ropivacaine—SCN1A—epilepsy syndrome	7.31e-05	0.0225	CrCbGaD
Lidocaine—CYP2B6—nervous system—epilepsy syndrome	7.12e-05	0.00483	CbGeAlD
Lidocaine—ABCB1—forebrain—epilepsy syndrome	7.01e-05	0.00476	CbGeAlD
Lidocaine—Tocainide—SCN1A—epilepsy syndrome	6.87e-05	0.0212	CrCbGaD
Lidocaine—CYP2B6—central nervous system—epilepsy syndrome	6.86e-05	0.00465	CbGeAlD
Lidocaine—ABCB1—telencephalon—epilepsy syndrome	6.45e-05	0.00437	CbGeAlD
Lidocaine—Ropivacaine—SCN2A—epilepsy syndrome	6.44e-05	0.0199	CrCbGaD
Lidocaine—Procainamide—SCN9A—epilepsy syndrome	6.32e-05	0.0195	CrCbGaD
Lidocaine—SLC22A5—brain—epilepsy syndrome	6.27e-05	0.00425	CbGeAlD
Lidocaine—CYP2C8—brain—epilepsy syndrome	6.07e-05	0.00412	CbGeAlD
Lidocaine—Tocainide—SCN2A—epilepsy syndrome	6.06e-05	0.0187	CrCbGaD
Lidocaine—Procainamide—SCN3A—epilepsy syndrome	6.04e-05	0.0186	CrCbGaD
Lidocaine—Procainamide—SCN4A—epilepsy syndrome	5.81e-05	0.0179	CrCbGaD
Lidocaine—CYP2D6—head—epilepsy syndrome	5.58e-05	0.00379	CbGeAlD
Lidocaine—CYP2B6—brain—epilepsy syndrome	5.44e-05	0.00369	CbGeAlD
Lidocaine—CYP3A4—nervous system—epilepsy syndrome	5.38e-05	0.00365	CbGeAlD
Lidocaine—CYP2D6—nervous system—epilepsy syndrome	5.29e-05	0.00359	CbGeAlD
Lidocaine—CYP3A4—central nervous system—epilepsy syndrome	5.18e-05	0.00351	CbGeAlD
Lidocaine—CYP2D6—central nervous system—epilepsy syndrome	5.09e-05	0.00346	CbGeAlD
Lidocaine—ABCB1—medulla oblongata—epilepsy syndrome	5.07e-05	0.00344	CbGeAlD
Lidocaine—CYP2D6—cerebellum—epilepsy syndrome	4.98e-05	0.00338	CbGeAlD
Lidocaine—ABCB1—midbrain—epilepsy syndrome	4.63e-05	0.00314	CbGeAlD
Lidocaine—ABCB1—spinal cord—epilepsy syndrome	4.52e-05	0.00306	CbGeAlD
Lidocaine—Procainamide—SCN1A—epilepsy syndrome	4.24e-05	0.0131	CrCbGaD
Lidocaine—CYP2D6—brain—epilepsy syndrome	4.04e-05	0.00274	CbGeAlD
Lidocaine—ABCB1—head—epilepsy syndrome	4.01e-05	0.00272	CbGeAlD
Lidocaine—ABCB1—nervous system—epilepsy syndrome	3.81e-05	0.00258	CbGeAlD
Lidocaine—Procainamide—SCN2A—epilepsy syndrome	3.74e-05	0.0115	CrCbGaD
Lidocaine—ABCB1—central nervous system—epilepsy syndrome	3.66e-05	0.00249	CbGeAlD
Lidocaine—Chloroprocaine—BCHE—epilepsy syndrome	3.65e-05	0.0112	CrCbGaD
Lidocaine—ABCB1—cerebellum—epilepsy syndrome	3.58e-05	0.00243	CbGeAlD
Lidocaine—ABCB1—brain—epilepsy syndrome	2.91e-05	0.00197	CbGeAlD
Lidocaine—Bupivacaine—CYP2C19—epilepsy syndrome	2.85e-05	0.00878	CrCbGaD
Lidocaine—Urticaria—Clonazepam—epilepsy syndrome	2.8e-05	0.000329	CcSEcCtD
Lidocaine—Eye disorder—Gabapentin—epilepsy syndrome	2.8e-05	0.000329	CcSEcCtD
Lidocaine—Tinnitus—Gabapentin—epilepsy syndrome	2.79e-05	0.000328	CcSEcCtD
Lidocaine—Dizziness—Midazolam—epilepsy syndrome	2.79e-05	0.000328	CcSEcCtD
Lidocaine—Tension—Pregabalin—epilepsy syndrome	2.79e-05	0.000328	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	2.79e-05	0.000328	CcSEcCtD
Lidocaine—Dysgeusia—Pregabalin—epilepsy syndrome	2.78e-05	0.000327	CcSEcCtD
Lidocaine—Urticaria—Phenytoin—epilepsy syndrome	2.78e-05	0.000327	CcSEcCtD
Lidocaine—Cardiac disorder—Gabapentin—epilepsy syndrome	2.78e-05	0.000326	CcSEcCtD
Lidocaine—Asthenia—Diazepam—epilepsy syndrome	2.77e-05	0.000325	CcSEcCtD
Lidocaine—Urticaria—Oxcarbazepine—epilepsy syndrome	2.77e-05	0.000325	CcSEcCtD
Lidocaine—Pain—Lamotrigine—epilepsy syndrome	2.76e-05	0.000324	CcSEcCtD
Lidocaine—Nervousness—Pregabalin—epilepsy syndrome	2.76e-05	0.000324	CcSEcCtD
Lidocaine—Nausea—Acetazolamide—epilepsy syndrome	2.76e-05	0.000324	CcSEcCtD
Lidocaine—Dizziness—Levetiracetam—epilepsy syndrome	2.76e-05	0.000324	CcSEcCtD
Lidocaine—Feeling abnormal—Carbamazepine—epilepsy syndrome	2.75e-05	0.000324	CcSEcCtD
Lidocaine—Neuropathy peripheral—Topiramate—epilepsy syndrome	2.75e-05	0.000323	CcSEcCtD
Lidocaine—Back pain—Pregabalin—epilepsy syndrome	2.75e-05	0.000323	CcSEcCtD
Lidocaine—Vomiting—Propofol—epilepsy syndrome	2.74e-05	0.000322	CcSEcCtD
Lidocaine—Stomatitis—Topiramate—epilepsy syndrome	2.74e-05	0.000321	CcSEcCtD
Lidocaine—Rash—Propofol—epilepsy syndrome	2.72e-05	0.00032	CcSEcCtD
Lidocaine—Dermatitis—Propofol—epilepsy syndrome	2.72e-05	0.000319	CcSEcCtD
Lidocaine—Hypertension—Valproic Acid—epilepsy syndrome	2.72e-05	0.000319	CcSEcCtD
Lidocaine—Immune system disorder—Gabapentin—epilepsy syndrome	2.71e-05	0.000318	CcSEcCtD
Lidocaine—Headache—Propofol—epilepsy syndrome	2.7e-05	0.000317	CcSEcCtD
Lidocaine—Hypersensitivity—Zonisamide—epilepsy syndrome	2.69e-05	0.000317	CcSEcCtD
Lidocaine—Chills—Gabapentin—epilepsy syndrome	2.69e-05	0.000316	CcSEcCtD
Lidocaine—Vomiting—Midazolam—epilepsy syndrome	2.68e-05	0.000315	CcSEcCtD
Lidocaine—Asthenia—Felbamate—epilepsy syndrome	2.68e-05	0.000315	CcSEcCtD
Lidocaine—Vision blurred—Pregabalin—epilepsy syndrome	2.68e-05	0.000315	CcSEcCtD
Lidocaine—Chest pain—Valproic Acid—epilepsy syndrome	2.68e-05	0.000314	CcSEcCtD
Lidocaine—Anxiety—Valproic Acid—epilepsy syndrome	2.67e-05	0.000313	CcSEcCtD
Lidocaine—Tremor—Pregabalin—epilepsy syndrome	2.66e-05	0.000313	CcSEcCtD
Lidocaine—Feeling abnormal—Lamotrigine—epilepsy syndrome	2.66e-05	0.000313	CcSEcCtD
Lidocaine—Rash—Midazolam—epilepsy syndrome	2.66e-05	0.000313	CcSEcCtD
Lidocaine—Dizziness—Fosphenytoin—epilepsy syndrome	2.66e-05	0.000312	CcSEcCtD
Lidocaine—Dermatitis—Midazolam—epilepsy syndrome	2.66e-05	0.000312	CcSEcCtD
Lidocaine—Urticaria—Carbamazepine—epilepsy syndrome	2.66e-05	0.000312	CcSEcCtD
Lidocaine—Vomiting—Levetiracetam—epilepsy syndrome	2.65e-05	0.000311	CcSEcCtD
Lidocaine—Headache—Midazolam—epilepsy syndrome	2.64e-05	0.000311	CcSEcCtD
Lidocaine—Rash—Levetiracetam—epilepsy syndrome	2.63e-05	0.000309	CcSEcCtD
Lidocaine—Dermatitis—Levetiracetam—epilepsy syndrome	2.63e-05	0.000308	CcSEcCtD
Lidocaine—Asthenia—Zonisamide—epilepsy syndrome	2.62e-05	0.000308	CcSEcCtD
Lidocaine—Agitation—Pregabalin—epilepsy syndrome	2.61e-05	0.000307	CcSEcCtD
Lidocaine—Headache—Levetiracetam—epilepsy syndrome	2.61e-05	0.000307	CcSEcCtD
Lidocaine—Erythema—Gabapentin—epilepsy syndrome	2.61e-05	0.000306	CcSEcCtD
Lidocaine—Angioedema—Pregabalin—epilepsy syndrome	2.6e-05	0.000305	CcSEcCtD
Lidocaine—Hypersensitivity—Clonazepam—epilepsy syndrome	2.6e-05	0.000305	CcSEcCtD
Lidocaine—Dizziness—Vigabatrin—epilepsy syndrome	2.59e-05	0.000305	CcSEcCtD
Lidocaine—Confusional state—Valproic Acid—epilepsy syndrome	2.59e-05	0.000304	CcSEcCtD
Lidocaine—Hypersensitivity—Phenytoin—epilepsy syndrome	2.58e-05	0.000303	CcSEcCtD
Lidocaine—Oedema—Valproic Acid—epilepsy syndrome	2.57e-05	0.000301	CcSEcCtD
Lidocaine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	2.57e-05	0.000301	CcSEcCtD
Lidocaine—Urticaria—Lamotrigine—epilepsy syndrome	2.57e-05	0.000301	CcSEcCtD
Lidocaine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	2.57e-05	0.000301	CcSEcCtD
Lidocaine—Bradycardia—Topiramate—epilepsy syndrome	2.57e-05	0.000301	CcSEcCtD
Lidocaine—Nausea—Propofol—epilepsy syndrome	2.56e-05	0.000301	CcSEcCtD
Lidocaine—Tension—Gabapentin—epilepsy syndrome	2.56e-05	0.000301	CcSEcCtD
Lidocaine—Vomiting—Fosphenytoin—epilepsy syndrome	2.56e-05	0.0003	CcSEcCtD
Lidocaine—Dysgeusia—Gabapentin—epilepsy syndrome	2.55e-05	0.0003	CcSEcCtD
Lidocaine—Dizziness—Diazepam—epilepsy syndrome	2.55e-05	0.0003	CcSEcCtD
Lidocaine—Rash—Fosphenytoin—epilepsy syndrome	2.54e-05	0.000298	CcSEcCtD
Lidocaine—Dermatitis—Fosphenytoin—epilepsy syndrome	2.53e-05	0.000298	CcSEcCtD
Lidocaine—Haemoglobin—Topiramate—epilepsy syndrome	2.53e-05	0.000297	CcSEcCtD
Lidocaine—Nervousness—Gabapentin—epilepsy syndrome	2.53e-05	0.000297	CcSEcCtD
Lidocaine—Asthenia—Clonazepam—epilepsy syndrome	2.53e-05	0.000297	CcSEcCtD
Lidocaine—Rhinitis—Topiramate—epilepsy syndrome	2.53e-05	0.000297	CcSEcCtD
Lidocaine—Back pain—Gabapentin—epilepsy syndrome	2.52e-05	0.000296	CcSEcCtD
Lidocaine—Headache—Fosphenytoin—epilepsy syndrome	2.52e-05	0.000296	CcSEcCtD
Lidocaine—Haemorrhage—Topiramate—epilepsy syndrome	2.52e-05	0.000296	CcSEcCtD
Lidocaine—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.52e-05	0.000296	CcSEcCtD
Lidocaine—Asthenia—Phenytoin—epilepsy syndrome	2.51e-05	0.000295	CcSEcCtD
Lidocaine—Nausea—Midazolam—epilepsy syndrome	2.51e-05	0.000294	CcSEcCtD
Lidocaine—Hypoaesthesia—Topiramate—epilepsy syndrome	2.51e-05	0.000294	CcSEcCtD
Lidocaine—Loss of consciousness—Pregabalin—epilepsy syndrome	2.5e-05	0.000294	CcSEcCtD
Lidocaine—Asthenia—Oxcarbazepine—epilepsy syndrome	2.5e-05	0.000294	CcSEcCtD
Lidocaine—Vomiting—Vigabatrin—epilepsy syndrome	2.49e-05	0.000293	CcSEcCtD
Lidocaine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.48e-05	0.000291	CcSEcCtD
Lidocaine—Nausea—Levetiracetam—epilepsy syndrome	2.48e-05	0.000291	CcSEcCtD
Lidocaine—Rash—Vigabatrin—epilepsy syndrome	2.47e-05	0.00029	CcSEcCtD
Lidocaine—Dizziness—Felbamate—epilepsy syndrome	2.47e-05	0.00029	CcSEcCtD
Lidocaine—Dermatitis—Vigabatrin—epilepsy syndrome	2.47e-05	0.00029	CcSEcCtD
Lidocaine—Convulsion—Pregabalin—epilepsy syndrome	2.46e-05	0.000289	CcSEcCtD
Lidocaine—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.46e-05	0.000289	CcSEcCtD
Lidocaine—Vision blurred—Gabapentin—epilepsy syndrome	2.46e-05	0.000289	CcSEcCtD
Lidocaine—Headache—Vigabatrin—epilepsy syndrome	2.46e-05	0.000289	CcSEcCtD
Lidocaine—Hypertension—Pregabalin—epilepsy syndrome	2.46e-05	0.000288	CcSEcCtD
Lidocaine—Vomiting—Diazepam—epilepsy syndrome	2.45e-05	0.000288	CcSEcCtD
Lidocaine—Tremor—Gabapentin—epilepsy syndrome	2.44e-05	0.000287	CcSEcCtD
Lidocaine—Rash—Diazepam—epilepsy syndrome	2.43e-05	0.000286	CcSEcCtD
Lidocaine—Dermatitis—Diazepam—epilepsy syndrome	2.43e-05	0.000286	CcSEcCtD
Lidocaine—Visual impairment—Topiramate—epilepsy syndrome	2.43e-05	0.000285	CcSEcCtD
Lidocaine—Chest pain—Pregabalin—epilepsy syndrome	2.42e-05	0.000284	CcSEcCtD
Lidocaine—Dizziness—Zonisamide—epilepsy syndrome	2.42e-05	0.000284	CcSEcCtD
Lidocaine—Headache—Diazepam—epilepsy syndrome	2.42e-05	0.000284	CcSEcCtD
Lidocaine—Anxiety—Pregabalin—epilepsy syndrome	2.41e-05	0.000283	CcSEcCtD
Lidocaine—Hypotension—Valproic Acid—epilepsy syndrome	2.4e-05	0.000282	CcSEcCtD
Lidocaine—Asthenia—Carbamazepine—epilepsy syndrome	2.4e-05	0.000282	CcSEcCtD
Lidocaine—Agitation—Gabapentin—epilepsy syndrome	2.4e-05	0.000281	CcSEcCtD
Lidocaine—Nausea—Fosphenytoin—epilepsy syndrome	2.39e-05	0.000281	CcSEcCtD
Lidocaine—Angioedema—Gabapentin—epilepsy syndrome	2.38e-05	0.00028	CcSEcCtD
Lidocaine—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.38e-05	0.00028	CcSEcCtD
Lidocaine—Vomiting—Felbamate—epilepsy syndrome	2.38e-05	0.000279	CcSEcCtD
Lidocaine—Rash—Felbamate—epilepsy syndrome	2.36e-05	0.000277	CcSEcCtD
Lidocaine—Eye disorder—Topiramate—epilepsy syndrome	2.36e-05	0.000277	CcSEcCtD
Lidocaine—Dermatitis—Felbamate—epilepsy syndrome	2.35e-05	0.000276	CcSEcCtD
Lidocaine—Tinnitus—Topiramate—epilepsy syndrome	2.35e-05	0.000276	CcSEcCtD
Lidocaine—Headache—Felbamate—epilepsy syndrome	2.34e-05	0.000275	CcSEcCtD
Lidocaine—Confusional state—Pregabalin—epilepsy syndrome	2.34e-05	0.000275	CcSEcCtD
Lidocaine—Cardiac disorder—Topiramate—epilepsy syndrome	2.34e-05	0.000275	CcSEcCtD
Lidocaine—Flushing—Topiramate—epilepsy syndrome	2.34e-05	0.000275	CcSEcCtD
Lidocaine—Dizziness—Clonazepam—epilepsy syndrome	2.33e-05	0.000274	CcSEcCtD
Lidocaine—Nausea—Vigabatrin—epilepsy syndrome	2.33e-05	0.000274	CcSEcCtD
Lidocaine—Vomiting—Zonisamide—epilepsy syndrome	2.33e-05	0.000273	CcSEcCtD
Lidocaine—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.32e-05	0.000273	CcSEcCtD
Lidocaine—Oedema—Pregabalin—epilepsy syndrome	2.32e-05	0.000273	CcSEcCtD
Lidocaine—Asthenia—Lamotrigine—epilepsy syndrome	2.32e-05	0.000272	CcSEcCtD
Lidocaine—Dizziness—Phenytoin—epilepsy syndrome	2.32e-05	0.000272	CcSEcCtD
Lidocaine—Rash—Zonisamide—epilepsy syndrome	2.31e-05	0.000271	CcSEcCtD
Lidocaine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.31e-05	0.000271	CcSEcCtD
Lidocaine—Dermatitis—Zonisamide—epilepsy syndrome	2.3e-05	0.000271	CcSEcCtD
Lidocaine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.3e-05	0.000271	CcSEcCtD
Lidocaine—Nausea—Diazepam—epilepsy syndrome	2.29e-05	0.000269	CcSEcCtD
Lidocaine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.29e-05	0.000269	CcSEcCtD
Lidocaine—Headache—Zonisamide—epilepsy syndrome	2.29e-05	0.000269	CcSEcCtD
Lidocaine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.29e-05	0.000269	CcSEcCtD
Lidocaine—Angiopathy—Topiramate—epilepsy syndrome	2.29e-05	0.000269	CcSEcCtD
Lidocaine—Shock—Pregabalin—epilepsy syndrome	2.28e-05	0.000268	CcSEcCtD
Lidocaine—Somnolence—Valproic Acid—epilepsy syndrome	2.28e-05	0.000268	CcSEcCtD
Lidocaine—Immune system disorder—Topiramate—epilepsy syndrome	2.28e-05	0.000267	CcSEcCtD
Lidocaine—Nervous system disorder—Pregabalin—epilepsy syndrome	2.28e-05	0.000267	CcSEcCtD
Lidocaine—Chills—Topiramate—epilepsy syndrome	2.26e-05	0.000266	CcSEcCtD
Lidocaine—Convulsion—Gabapentin—epilepsy syndrome	2.26e-05	0.000265	CcSEcCtD
Lidocaine—Hypertension—Gabapentin—epilepsy syndrome	2.25e-05	0.000264	CcSEcCtD
Lidocaine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.24e-05	0.000263	CcSEcCtD
Lidocaine—Vomiting—Clonazepam—epilepsy syndrome	2.24e-05	0.000263	CcSEcCtD
Lidocaine—Vomiting—Phenytoin—epilepsy syndrome	2.23e-05	0.000261	CcSEcCtD
Lidocaine—Rash—Clonazepam—epilepsy syndrome	2.22e-05	0.000261	CcSEcCtD
Lidocaine—Dermatitis—Clonazepam—epilepsy syndrome	2.22e-05	0.000261	CcSEcCtD
Lidocaine—Chest pain—Gabapentin—epilepsy syndrome	2.22e-05	0.000261	CcSEcCtD
Lidocaine—Nausea—Felbamate—epilepsy syndrome	2.22e-05	0.000261	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.22e-05	0.00026	CcSEcCtD
Lidocaine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.21e-05	0.00026	CcSEcCtD
Lidocaine—Anxiety—Gabapentin—epilepsy syndrome	2.21e-05	0.00026	CcSEcCtD
Lidocaine—Dizziness—Carbamazepine—epilepsy syndrome	2.21e-05	0.00026	CcSEcCtD
Lidocaine—Headache—Clonazepam—epilepsy syndrome	2.21e-05	0.000259	CcSEcCtD
Lidocaine—Rash—Phenytoin—epilepsy syndrome	2.21e-05	0.000259	CcSEcCtD
Lidocaine—Dermatitis—Phenytoin—epilepsy syndrome	2.21e-05	0.000259	CcSEcCtD
Lidocaine—Rash—Oxcarbazepine—epilepsy syndrome	2.2e-05	0.000258	CcSEcCtD
Lidocaine—Pain—Valproic Acid—epilepsy syndrome	2.2e-05	0.000258	CcSEcCtD
Lidocaine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.19e-05	0.000258	CcSEcCtD
Lidocaine—Headache—Phenytoin—epilepsy syndrome	2.19e-05	0.000258	CcSEcCtD
Lidocaine—Erythema—Topiramate—epilepsy syndrome	2.19e-05	0.000258	CcSEcCtD
Lidocaine—Headache—Oxcarbazepine—epilepsy syndrome	2.18e-05	0.000256	CcSEcCtD
Lidocaine—Nausea—Zonisamide—epilepsy syndrome	2.17e-05	0.000255	CcSEcCtD
Lidocaine—Hypotension—Pregabalin—epilepsy syndrome	2.17e-05	0.000255	CcSEcCtD
Lidocaine—Procainamide—CHRM2—epilepsy syndrome	2.16e-05	0.00666	CrCbGaD
Lidocaine—Tension—Topiramate—epilepsy syndrome	2.15e-05	0.000253	CcSEcCtD
Lidocaine—Dysgeusia—Topiramate—epilepsy syndrome	2.15e-05	0.000252	CcSEcCtD
Lidocaine—Confusional state—Gabapentin—epilepsy syndrome	2.15e-05	0.000252	CcSEcCtD
Lidocaine—Dizziness—Lamotrigine—epilepsy syndrome	2.14e-05	0.000251	CcSEcCtD
Lidocaine—Nervousness—Topiramate—epilepsy syndrome	2.13e-05	0.00025	CcSEcCtD
Lidocaine—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.13e-05	0.00025	CcSEcCtD
Lidocaine—Oedema—Gabapentin—epilepsy syndrome	2.13e-05	0.00025	CcSEcCtD
Lidocaine—Vomiting—Carbamazepine—epilepsy syndrome	2.13e-05	0.00025	CcSEcCtD
Lidocaine—Back pain—Topiramate—epilepsy syndrome	2.12e-05	0.000249	CcSEcCtD
Lidocaine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.12e-05	0.000248	CcSEcCtD
Lidocaine—Bupivacaine—CYP2D6—epilepsy syndrome	2.11e-05	0.00651	CrCbGaD
Lidocaine—Rash—Carbamazepine—epilepsy syndrome	2.11e-05	0.000248	CcSEcCtD
Lidocaine—Dermatitis—Carbamazepine—epilepsy syndrome	2.11e-05	0.000247	CcSEcCtD
Lidocaine—Nausea—Clonazepam—epilepsy syndrome	2.09e-05	0.000246	CcSEcCtD
Lidocaine—Headache—Carbamazepine—epilepsy syndrome	2.09e-05	0.000246	CcSEcCtD
Lidocaine—Shock—Gabapentin—epilepsy syndrome	2.09e-05	0.000246	CcSEcCtD
Lidocaine—Nervous system disorder—Gabapentin—epilepsy syndrome	2.09e-05	0.000245	CcSEcCtD
Lidocaine—Paraesthesia—Pregabalin—epilepsy syndrome	2.08e-05	0.000245	CcSEcCtD
Lidocaine—Nausea—Phenytoin—epilepsy syndrome	2.08e-05	0.000244	CcSEcCtD
Lidocaine—Dyspnoea—Pregabalin—epilepsy syndrome	2.07e-05	0.000243	CcSEcCtD
Lidocaine—Nausea—Oxcarbazepine—epilepsy syndrome	2.07e-05	0.000243	CcSEcCtD
Lidocaine—Vision blurred—Topiramate—epilepsy syndrome	2.07e-05	0.000243	CcSEcCtD
Lidocaine—Somnolence—Pregabalin—epilepsy syndrome	2.06e-05	0.000242	CcSEcCtD
Lidocaine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.06e-05	0.000242	CcSEcCtD
Lidocaine—Tremor—Topiramate—epilepsy syndrome	2.06e-05	0.000241	CcSEcCtD
Lidocaine—Vomiting—Lamotrigine—epilepsy syndrome	2.05e-05	0.000241	CcSEcCtD
Lidocaine—Urticaria—Valproic Acid—epilepsy syndrome	2.04e-05	0.00024	CcSEcCtD
Lidocaine—Rash—Lamotrigine—epilepsy syndrome	2.04e-05	0.000239	CcSEcCtD
Lidocaine—Dermatitis—Lamotrigine—epilepsy syndrome	2.03e-05	0.000239	CcSEcCtD
Lidocaine—Headache—Lamotrigine—epilepsy syndrome	2.02e-05	0.000238	CcSEcCtD
Lidocaine—Agitation—Topiramate—epilepsy syndrome	2.02e-05	0.000237	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2e-05	0.000235	CcSEcCtD
Lidocaine—Hypotension—Gabapentin—epilepsy syndrome	1.99e-05	0.000234	CcSEcCtD
Lidocaine—Nausea—Carbamazepine—epilepsy syndrome	1.99e-05	0.000233	CcSEcCtD
Lidocaine—Pain—Pregabalin—epilepsy syndrome	1.98e-05	0.000233	CcSEcCtD
Lidocaine—Loss of consciousness—Topiramate—epilepsy syndrome	1.93e-05	0.000226	CcSEcCtD
Lidocaine—Nausea—Lamotrigine—epilepsy syndrome	1.92e-05	0.000225	CcSEcCtD
Lidocaine—Feeling abnormal—Pregabalin—epilepsy syndrome	1.91e-05	0.000225	CcSEcCtD
Lidocaine—Paraesthesia—Gabapentin—epilepsy syndrome	1.91e-05	0.000224	CcSEcCtD
Lidocaine—Convulsion—Topiramate—epilepsy syndrome	1.9e-05	0.000223	CcSEcCtD
Lidocaine—Dyspnoea—Gabapentin—epilepsy syndrome	1.9e-05	0.000223	CcSEcCtD
Lidocaine—Hypertension—Topiramate—epilepsy syndrome	1.89e-05	0.000222	CcSEcCtD
Lidocaine—Somnolence—Gabapentin—epilepsy syndrome	1.89e-05	0.000222	CcSEcCtD
Lidocaine—Hypersensitivity—Valproic Acid—epilepsy syndrome	1.89e-05	0.000222	CcSEcCtD
Lidocaine—Chest pain—Topiramate—epilepsy syndrome	1.87e-05	0.000219	CcSEcCtD
Lidocaine—Anxiety—Topiramate—epilepsy syndrome	1.86e-05	0.000219	CcSEcCtD
Lidocaine—Urticaria—Pregabalin—epilepsy syndrome	1.84e-05	0.000217	CcSEcCtD
Lidocaine—Asthenia—Valproic Acid—epilepsy syndrome	1.84e-05	0.000216	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.84e-05	0.000216	CcSEcCtD
Lidocaine—Pain—Gabapentin—epilepsy syndrome	1.82e-05	0.000214	CcSEcCtD
Lidocaine—Confusional state—Topiramate—epilepsy syndrome	1.81e-05	0.000212	CcSEcCtD
Lidocaine—Procainamide—BCHE—epilepsy syndrome	1.8e-05	0.00555	CrCbGaD
Lidocaine—Oedema—Topiramate—epilepsy syndrome	1.79e-05	0.00021	CcSEcCtD
Lidocaine—Shock—Topiramate—epilepsy syndrome	1.76e-05	0.000207	CcSEcCtD
Lidocaine—Nervous system disorder—Topiramate—epilepsy syndrome	1.76e-05	0.000206	CcSEcCtD
Lidocaine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.75e-05	0.000206	CcSEcCtD
Lidocaine—Hyperhidrosis—Topiramate—epilepsy syndrome	1.73e-05	0.000203	CcSEcCtD
Lidocaine—Hypersensitivity—Pregabalin—epilepsy syndrome	1.71e-05	0.000201	CcSEcCtD
Lidocaine—Ropivacaine—CYP2D6—epilepsy syndrome	1.7e-05	0.00524	CrCbGaD
Lidocaine—Dizziness—Valproic Acid—epilepsy syndrome	1.7e-05	0.000199	CcSEcCtD
Lidocaine—Urticaria—Gabapentin—epilepsy syndrome	1.69e-05	0.000199	CcSEcCtD
Lidocaine—Hypotension—Topiramate—epilepsy syndrome	1.67e-05	0.000196	CcSEcCtD
Lidocaine—Asthenia—Pregabalin—epilepsy syndrome	1.67e-05	0.000196	CcSEcCtD
Lidocaine—Vomiting—Valproic Acid—epilepsy syndrome	1.63e-05	0.000192	CcSEcCtD
Lidocaine—Rash—Valproic Acid—epilepsy syndrome	1.62e-05	0.00019	CcSEcCtD
Lidocaine—Dermatitis—Valproic Acid—epilepsy syndrome	1.62e-05	0.00019	CcSEcCtD
Lidocaine—Headache—Valproic Acid—epilepsy syndrome	1.61e-05	0.000189	CcSEcCtD
Lidocaine—Paraesthesia—Topiramate—epilepsy syndrome	1.61e-05	0.000189	CcSEcCtD
Lidocaine—Dyspnoea—Topiramate—epilepsy syndrome	1.6e-05	0.000187	CcSEcCtD
Lidocaine—Somnolence—Topiramate—epilepsy syndrome	1.59e-05	0.000187	CcSEcCtD
Lidocaine—Hypersensitivity—Gabapentin—epilepsy syndrome	1.57e-05	0.000184	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.55e-05	0.000182	CcSEcCtD
Lidocaine—Dizziness—Pregabalin—epilepsy syndrome	1.53e-05	0.00018	CcSEcCtD
Lidocaine—Pain—Topiramate—epilepsy syndrome	1.53e-05	0.00018	CcSEcCtD
Lidocaine—Asthenia—Gabapentin—epilepsy syndrome	1.53e-05	0.000179	CcSEcCtD
Lidocaine—Nausea—Valproic Acid—epilepsy syndrome	1.52e-05	0.000179	CcSEcCtD
Lidocaine—Vomiting—Pregabalin—epilepsy syndrome	1.48e-05	0.000173	CcSEcCtD
Lidocaine—Feeling abnormal—Topiramate—epilepsy syndrome	1.48e-05	0.000173	CcSEcCtD
Lidocaine—Rash—Pregabalin—epilepsy syndrome	1.46e-05	0.000172	CcSEcCtD
Lidocaine—Dermatitis—Pregabalin—epilepsy syndrome	1.46e-05	0.000172	CcSEcCtD
Lidocaine—Headache—Pregabalin—epilepsy syndrome	1.45e-05	0.000171	CcSEcCtD
Lidocaine—Urticaria—Topiramate—epilepsy syndrome	1.42e-05	0.000167	CcSEcCtD
Lidocaine—Dizziness—Gabapentin—epilepsy syndrome	1.41e-05	0.000165	CcSEcCtD
Lidocaine—Nausea—Pregabalin—epilepsy syndrome	1.38e-05	0.000162	CcSEcCtD
Lidocaine—Vomiting—Gabapentin—epilepsy syndrome	1.35e-05	0.000159	CcSEcCtD
Lidocaine—Rash—Gabapentin—epilepsy syndrome	1.34e-05	0.000158	CcSEcCtD
Lidocaine—Dermatitis—Gabapentin—epilepsy syndrome	1.34e-05	0.000157	CcSEcCtD
Lidocaine—Headache—Gabapentin—epilepsy syndrome	1.33e-05	0.000157	CcSEcCtD
Lidocaine—Hypersensitivity—Topiramate—epilepsy syndrome	1.32e-05	0.000155	CcSEcCtD
Lidocaine—Asthenia—Topiramate—epilepsy syndrome	1.28e-05	0.000151	CcSEcCtD
Lidocaine—Nausea—Gabapentin—epilepsy syndrome	1.26e-05	0.000148	CcSEcCtD
Lidocaine—Tocainide—ALB—epilepsy syndrome	1.2e-05	0.00369	CrCbGaD
Lidocaine—Dizziness—Topiramate—epilepsy syndrome	1.18e-05	0.000139	CcSEcCtD
Lidocaine—Vomiting—Topiramate—epilepsy syndrome	1.14e-05	0.000134	CcSEcCtD
Lidocaine—Rash—Topiramate—epilepsy syndrome	1.13e-05	0.000133	CcSEcCtD
Lidocaine—Dermatitis—Topiramate—epilepsy syndrome	1.13e-05	0.000132	CcSEcCtD
Lidocaine—Headache—Topiramate—epilepsy syndrome	1.12e-05	0.000132	CcSEcCtD
Lidocaine—Nausea—Topiramate—epilepsy syndrome	1.06e-05	0.000125	CcSEcCtD
Lidocaine—Procainamide—CYP2D6—epilepsy syndrome	9.88e-06	0.00305	CrCbGaD
Lidocaine—EGFR—Developmental Biology—TNF—epilepsy syndrome	1.32e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	1.31e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.31e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.31e-06	2.36e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	1.31e-06	2.35e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	1.29e-06	2.32e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	1.29e-06	2.31e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	1.28e-06	2.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—S100B—epilepsy syndrome	1.28e-06	2.3e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.28e-06	2.29e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	1.27e-06	2.29e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—IL6ST—epilepsy syndrome	1.27e-06	2.28e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SOCS3—epilepsy syndrome	1.27e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.26e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.26e-06	2.27e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	1.26e-06	2.27e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDC42—epilepsy syndrome	1.26e-06	2.27e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FOS—epilepsy syndrome	1.26e-06	2.26e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOS2—epilepsy syndrome	1.26e-06	2.26e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—BCHE—epilepsy syndrome	1.26e-06	2.26e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.25e-06	2.25e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.24e-06	2.23e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.23e-06	2.22e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ALB—epilepsy syndrome	1.23e-06	2.22e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CASP8—epilepsy syndrome	1.23e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.23e-06	2.21e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	1.23e-06	2.21e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AVP—epilepsy syndrome	1.22e-06	2.2e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.22e-06	2.2e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GPX1—epilepsy syndrome	1.22e-06	2.19e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	1.21e-06	2.18e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—TH—epilepsy syndrome	1.21e-06	2.17e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.2e-06	2.16e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	1.2e-06	2.16e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.2e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.2e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.2e-06	2.15e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.19e-06	2.14e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	1.19e-06	2.13e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—TH—epilepsy syndrome	1.18e-06	2.12e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HES1—epilepsy syndrome	1.16e-06	2.08e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.15e-06	2.07e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	1.15e-06	2.06e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.15e-06	2.06e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.14e-06	2.05e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.14e-06	2.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FYN—epilepsy syndrome	1.12e-06	2.02e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.12e-06	2.01e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.12e-06	2.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—H2AFX—epilepsy syndrome	1.12e-06	2.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MEF2C—epilepsy syndrome	1.12e-06	2.01e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.12e-06	2.01e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.12e-06	2.01e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.12e-06	2.01e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FGF2—epilepsy syndrome	1.11e-06	2e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.11e-06	1.99e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.1e-06	1.97e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	1.09e-06	1.97e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—BCHE—epilepsy syndrome	1.09e-06	1.96e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—YWHAZ—epilepsy syndrome	1.08e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.08e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	1.94e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.07e-06	1.93e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.07e-06	1.92e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NGF—epilepsy syndrome	1.07e-06	1.92e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.07e-06	1.92e-05	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.06e-06	1.9e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—BCL2—epilepsy syndrome	1.06e-06	1.9e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.05e-06	1.89e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.05e-06	1.89e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.05e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.05e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.04e-06	1.88e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.04e-06	1.87e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCR5—epilepsy syndrome	1.04e-06	1.87e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.04e-06	1.87e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.04e-06	1.86e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—RELA—epilepsy syndrome	1.03e-06	1.85e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.03e-06	1.85e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.03e-06	1.85e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—FGF2—epilepsy syndrome	1.03e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—TH—epilepsy syndrome	1.02e-06	1.84e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.02e-06	1.84e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR2A—epilepsy syndrome	1.02e-06	1.83e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MTOR—epilepsy syndrome	1.01e-06	1.82e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.01e-06	1.81e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.01e-06	1.81e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1e-06	1.8e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CAT—epilepsy syndrome	9.96e-07	1.79e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	9.87e-07	1.77e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.86e-07	1.77e-05	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—AKT1—epilepsy syndrome	9.79e-07	1.76e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AGT—epilepsy syndrome	9.79e-07	1.76e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CAT—epilepsy syndrome	9.74e-07	1.75e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	9.69e-07	1.74e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TSC2—epilepsy syndrome	9.67e-07	1.74e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AGT—epilepsy syndrome	9.65e-07	1.73e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—APOE—epilepsy syndrome	9.59e-07	1.72e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	9.57e-07	1.72e-05	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.55e-07	1.72e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	9.53e-07	1.71e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—BCHE—epilepsy syndrome	9.49e-07	1.7e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	9.47e-07	1.7e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—APOE—epilepsy syndrome	9.46e-07	1.7e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.38e-07	1.68e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	9.35e-07	1.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—MTOR—epilepsy syndrome	9.34e-07	1.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL1B—epilepsy syndrome	9.33e-07	1.68e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—KDR—epilepsy syndrome	9.27e-07	1.66e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—epilepsy syndrome	9.26e-07	1.66e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	9.14e-07	1.64e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	9.05e-07	1.63e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—JUN—epilepsy syndrome	9.04e-07	1.62e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	9.01e-07	1.62e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—POMC—epilepsy syndrome	8.99e-07	1.62e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	8.98e-07	1.61e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PLCB1—epilepsy syndrome	8.96e-07	1.61e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	8.94e-07	1.61e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—TH—epilepsy syndrome	8.92e-07	1.6e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PRKCB—epilepsy syndrome	8.92e-07	1.6e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	8.91e-07	1.6e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	8.9e-07	1.6e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL6ST—epilepsy syndrome	8.88e-07	1.6e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	8.87e-07	1.59e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	8.86e-07	1.59e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GPX1—epilepsy syndrome	8.81e-07	1.58e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.79e-07	1.58e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	8.66e-07	1.56e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	8.66e-07	1.56e-05	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—AKT1—epilepsy syndrome	8.65e-07	1.55e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	8.55e-07	1.54e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	8.53e-07	1.53e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	8.46e-07	1.52e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	8.44e-07	1.52e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CAT—epilepsy syndrome	8.44e-07	1.52e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—TH—epilepsy syndrome	8.41e-07	1.51e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	8.37e-07	1.5e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—TH—epilepsy syndrome	8.34e-07	1.5e-05	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—epilepsy syndrome	8.31e-07	1.49e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—POMC—epilepsy syndrome	8.24e-07	1.48e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.21e-07	1.47e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	8.21e-07	1.47e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—epilepsy syndrome	8.2e-07	1.47e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—POMC—epilepsy syndrome	8.13e-07	1.46e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SRC—epilepsy syndrome	8.11e-07	1.46e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.02e-07	1.44e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	7.99e-07	1.44e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCL2—epilepsy syndrome	7.95e-07	1.43e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AGT—epilepsy syndrome	7.9e-07	1.42e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—APOE—epilepsy syndrome	7.74e-07	1.39e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AGT—epilepsy syndrome	7.72e-07	1.39e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GPX1—epilepsy syndrome	7.63e-07	1.37e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	7.61e-07	1.37e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	7.58e-07	1.36e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—APOE—epilepsy syndrome	7.57e-07	1.36e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—epilepsy syndrome	7.51e-07	1.35e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—SRC—epilepsy syndrome	7.49e-07	1.34e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—HMOX1—epilepsy syndrome	7.45e-07	1.34e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CAT—epilepsy syndrome	7.35e-07	1.32e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	7.23e-07	1.3e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FGF2—epilepsy syndrome	7.19e-07	1.29e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	7.17e-07	1.29e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	7.15e-07	1.28e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TH—epilepsy syndrome	7.12e-07	1.28e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.06e-07	1.27e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.02e-07	1.26e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.01e-07	1.26e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	6.96e-07	1.25e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.92e-07	1.24e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.88e-07	1.24e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CAT—epilepsy syndrome	6.87e-07	1.23e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.83e-07	1.23e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.74e-07	1.21e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AGT—epilepsy syndrome	6.69e-07	1.2e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.68e-07	1.2e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RELA—epilepsy syndrome	6.67e-07	1.2e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—POMC—epilepsy syndrome	6.65e-07	1.19e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.65e-07	1.19e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	6.57e-07	1.18e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—APOE—epilepsy syndrome	6.55e-07	1.18e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MTOR—epilepsy syndrome	6.54e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—POMC—epilepsy syndrome	6.5e-07	1.17e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.26e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	6.21e-07	1.12e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.17e-07	1.11e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—epilepsy syndrome	6.06e-07	1.09e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—epilepsy syndrome	6.02e-07	1.08e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	5.95e-07	1.07e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—epilepsy syndrome	5.93e-07	1.06e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.87e-07	1.05e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CAT—epilepsy syndrome	5.87e-07	1.05e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.85e-07	1.05e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—JUN—epilepsy syndrome	5.84e-07	1.05e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AGT—epilepsy syndrome	5.83e-07	1.05e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—APOE—epilepsy syndrome	5.71e-07	1.03e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	5.71e-07	1.03e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—epilepsy syndrome	5.69e-07	1.02e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—POMC—epilepsy syndrome	5.63e-07	1.01e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.58e-07	1e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.52e-07	9.91e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—epilepsy syndrome	5.51e-07	9.91e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TH—epilepsy syndrome	5.5e-07	9.88e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.49e-07	9.86e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.44e-07	9.78e-06	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—epilepsy syndrome	5.42e-07	9.74e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.38e-07	9.66e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—APOE—epilepsy syndrome	5.33e-07	9.58e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	5.31e-07	9.53e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	5.3e-07	9.53e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SRC—epilepsy syndrome	5.24e-07	9.42e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	5.18e-07	9.31e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—epilepsy syndrome	5.13e-07	9.22e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—epilepsy syndrome	5.11e-07	9.17e-06	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—epilepsy syndrome	5.04e-07	9.05e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—POMC—epilepsy syndrome	4.91e-07	8.81e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AGT—epilepsy syndrome	4.65e-07	8.36e-06	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—epilepsy syndrome	4.65e-07	8.36e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.62e-07	8.3e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.59e-07	8.24e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.58e-07	8.23e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—APOE—epilepsy syndrome	4.56e-07	8.19e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.53e-07	8.13e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	4.49e-07	8.07e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—epilepsy syndrome	4.47e-07	8.03e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.4e-07	7.91e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.21e-07	7.57e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.18e-07	7.5e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.09e-07	7.35e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—POMC—epilepsy syndrome	3.92e-07	7.03e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.91e-07	7.03e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.69e-07	6.62e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.65e-07	6.57e-06	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—epilepsy syndrome	3.6e-07	6.48e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.59e-07	6.45e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—epilepsy syndrome	3.57e-07	6.41e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.52e-07	6.32e-06	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	3.3e-07	5.94e-06	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—epilepsy syndrome	3.26e-07	5.85e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.12e-07	5.61e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.02e-07	5.43e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.76e-07	4.95e-06	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	2.67e-07	4.79e-06	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—epilepsy syndrome	2.61e-07	4.68e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.41e-07	4.33e-06	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—epilepsy syndrome	2.26e-07	4.05e-06	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.97e-07	3.53e-06	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.85e-07	3.33e-06	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.84e-07	3.3e-06	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.57e-07	2.82e-06	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.21e-07	2.18e-06	CbGpPWpGaD
